Alzheimer's Disease

The purpose of this study is to investigate a product that could potentially treat and restore cognitive function in Alzheimer's patients..

The current standard of care for people with Alzheimer's consists of FDA and EMA approved drugs that help improve symptoms and have limited impact on slowing disease progression. This research study focuses on treatment, slowing disease progression and restoring cognitive function.

We are currently enrolling volunteers for this study.